Five doors into health. None of them is a shortcut.
The quote set is fixed: LLY, JNJ, HIMS, MRNA and UNH. Each ticker indexes a different medical research lane while its contract record stays firmly in the market file.
The official Robinhood asset API listed these five quote-asset deployments as ASSET_STATUS_ACTIVE on chain 4663 at . That timestamp is the finding. It is not a pulse oximeter attached to the market and it is not proof of an ONCALL pool.
Active metadata does not establish PAR priceability, route depth, executable liquidity, suitability or investment merit. Any failed technical check blocks a launch decision and requires an explicit new record; no quote identity is silently swapped.
Theme / Metabolism & metabolic medicine
Science research track
obesity, diabetes, metabolic medicine, cardiometabolic outcomes
The metabolic-medicine theme is an editorial topic, not proof of a treatment benefit, company endorsement, or quote-market suitability.
Theme / Evidence-based clinical medicine & medical technology
Science research track
broad clinical medicine, medical technology, evidence appraisal
A broad clinical-evidence theme cannot stand in for evaluating individual studies or the separate risks of this quote asset.
Theme / Digital health & patient communication
Science research track
digital health, telemedicine, patient communication
A digital-health theme does not validate any service or health claim. The active API entry does not establish an executable PAR route.
Theme / Molecular medicine, immunology & vaccine science
Science research track
molecular medicine, immunology, vaccine science
Molecular-medicine education does not establish the success of a research program or the future value or liquidity of this quote asset.
Theme / Health systems, outcomes & population health
Science research track
health systems, outcomes research, population health
A health-systems theme is not a judgment about care quality, insurance coverage, or investment merit. Route depth still needs measurement.
The research tracks are editorial metadata, never sponsorship, endorsement or clinical validation. Scientific titles and conclusions stay brand-neutral in Science Notes. Company and market interpretation belongs in Market Rounds. Platform mechanics and limitations live in Robinhood Chain and Sources & Risks.
